Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
EASD 24: Prespecified Analysis from the SELECT Trial
Author(s): Helen Colhoun Added: 8 months ago
EASD 24 - We are joined by Dr Helen Coulhoun (University of Edinburgh, UK) to discuss the key findings of a prespecified analysis of the SELECT trial, which investigated the effectiveness of semaglutide in reducing major cardiac events in the presence of impaired kidney function in patients with overweight and obesity.Findings showed that participants in the study with reduced eGFR and/or… View more

Prevention & Chronic Conditions

Cardiovascular Renal Metabolic
ECO 24: Long-Term Weight Loss in the SELECT trial
Author(s): Donna H Ryan Added: 1 year ago
ECO 2024 — Dr Donna H Ryan (Pennington Biomedical Research Center, US) joins us to discuss the first sub-analysis of the landmark SELECT trial (NCT03574597, Novo Nordisk).In this study, investigators looked at long-term weight loss with semaglutide 2.4 mg compared to a placebo among 17,604 participants. In SELECT, at 208 weeks, semaglutide produced clinically significant weight loss compared to… View more

Heart Failure

Prevention & Chronic Conditions
CardioNerds @AHA23: SELECT: Effects of Semaglutide on Heart Disease & Stroke in Obese Patients
Author(s): A Michael Lincoff , Ahmed Ghoneem Added: 1 year ago
AHA 2023 - Investigator, Dr A Michael Lincoff (Cleveland Clinic, US) is interviewed by Dr Ahmed Ghoneem (UPMC Harrisburg, US), CardioNerds Ambassador, on the findings of the SELECT Trial (NCT03574597).SELECT is a randomised trial aiming to determine if semaglutide can reduce the risk of cardiovascular events in patients with overweight or obesity and prior cardiovascular disease. 17609 patients… View more

Guidelines & Statements

Prevention & Chronic Conditions
AHA 23 Late-Breaker Discussion: The SELECT Trial
Author(s): A Michael Lincoff , Harriette Van Spall Added: 1 year ago
AHA 2023 — Investigator, Dr A Michael Lincoff (Cleveland Clinic, US) sat down with Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the SELECT trial (NCT03574597).In this randomized, double-blind, parallel-group, placebo-controlled trial sponsored by Novo Nordisk, semaglutide was compared with a placebo in patients who have overweight or obesity and a history of… View more

Guidelines & Statements

Prevention & Chronic Conditions
Diagnostic Testing for Sleep Apnea in Heart Failure
Author(s): Marat Fudim Added: 2 weeks ago
In this short interview, Dr Marat Fudim offers a preview of his upcoming manuscript, set to appear in the Sleep Disordered Breathing in Heart Failure special focus collection in Cardiac Failure Review. He discusses the evolving role of home sleep testing in diagnosing sleep apnea in patients with heart failure, addressing key considerations in clinical workflows and patient selection.Watch now to… View more

Heart Failure
ACC.24: The TACTiC Trial
Author(s): Steven E Nissen Added: 1 year ago
ACC.24 — Investigator, Dr Steven Nissen (Cleveland Clinic, US) joins us onsite to discuss the findings of a trial designed to evaluate the extent to which participants could safely and effectively select, purchase and use rosuvastatin calcium 5mg for a 6-month trial period (NCT04964544).The TACTiC trial is a single-arm interventional, phase III self-selection and actual use study implementing a… View more

Digital Health

Prevention & Chronic Conditions
View from the Thoraxcenter: AHA 24 Wrap-Up
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 5 months ago
Keep up to date with the top trials from AHA 24!CLEAR-SYNERGYSELECT-CABGSUMMITYELLOW IIIInternational Aortic Stenosis RegistryAMPLATZER IDEVALOR HCMWatch our full AHA 24 coverage in our Late-Breaking and Featured Science Collection. View more

Heart Failure

Intervention
Dr Sebastian Billig is a Graduate Student at the Department of Anesthesiology at University Hospital RWTH Aachen. Dr Billig’s abstract was selected for oral presentation at the 6th A-CURE symposium. View more
Dr Peter Frederiksen is a PhD student from the Department of Cardiology at Odense University Hospital in Southern Denmark. Dr Frederiksen’s abstract was selected for oral presentation at the 6th A-CURE symposium. View more
Dr Sakata is a cardiothoracic surgeon and a postdoctoral fellow in the Kiyotake Ishikawa laboratory at the Cardiovascular Research Institute, Icahn School of Medicine at Mount Sinai. Dr Sakata was awarded the 2021 A-CURE Research Fellowship Grant. His abstract was selected for oral presentation at the 6th A-CURE Symposium. View more